Novartis Mulls Sale of Opthalmology, Respiratory Businesses, Bloomberg Reports
16 Novembro 2022 - 12:17PM
Dow Jones News
--Novartis AG is considering selling assets including its
respiratory and ophthalmology businesses as it seeks to invest in
innovative medicines, Bloomberg reports, citing unnamed
sources.
--The Swiss pharma major's ophthalmology business alone could be
worth about $5 billion, according to Bloomberg.
--Any sales of the businesses are likely to start in 2023 but
there is no certainty that the deliberations will result in
disposals, Bloomberg reports.
Full story: https://bloom.bg/3txZE7V
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
November 16, 2022 10:02 ET (15:02 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Novartis (NYSE:NVS)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024